Cargando…

Iron at the Interface of Hepatocellular Carcinoma

Cancer incidence and mortality are rapidly growing, with liver cancer being the sixth most diagnosed cancer worldwide and the third leading cause of cancer death in 2020. A number of risk factors have been identified that trigger the progression to hepatocellular carcinoma. In this review, we focus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paganoni, Rossana, Lechel, André, Vujic Spasic, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071427/ https://www.ncbi.nlm.nih.gov/pubmed/33921027 http://dx.doi.org/10.3390/ijms22084097

Ejemplares similares

Hfe Actions in Kupffer Cells Are Dispensable for Hepatic and Systemic Iron Metabolism
por: Knoop, Paul, et al.
Publicado: (2023)

Seasonal and fasting induced changes in iron metabolism in Djungarian hamsters
por: Kawach, Rawan, et al.
Publicado: (2023)

Systems analysis of iron metabolism: the network of iron pools and fluxes
por: Lopes, Tiago JS, et al.
Publicado: (2010)

Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
por: Tangudu, Naveen Kumar, et al.
Publicado: (2019)

Total reflection X-ray fluorescence spectrometry for trace determination of iron and some additional elements in biological samples
por: Gruber, Andreas, et al.
Publicado: (2020)

Macrophage-HFE controls iron metabolism and immune responses in aged mice
por: Tangudu, Naveen Kumar, et al.
Publicado: (2020)

Despite Genetic Iron Overload, Hfe‐Hemochromatosis Mice Do Not Show Bone Loss
por: Wagner, Alessa, et al.
Publicado: (2019)

Scavenging Reactive Oxygen Species Production Normalizes Ferroportin Expression and Ameliorates Cellular and Systemic Iron Disbalances in Hemolytic Mouse Model
por: Tangudu, Naveen Kumar, et al.
Publicado: (2018)

Telomerase: The Devil Inside
por: Kumar, Mukesh, et al.
Publicado: (2016)

Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
por: Keenan, Bridget P., et al.
Publicado: (2019)

Remodelling and Improvements in Organoid Technology to Study Liver Carcinogenesis in a Dish
por: Tharehalli, Umesh, et al.
Publicado: (2019)

P1491: THE DYNAMIC INTERACTION BETWEEN INFLAMMATION AND THE IRON SENSOR HFE, IN SEVERE MALARIA-INDUCED ANEMIA
por: Pêgo, Ana, et al.
Publicado: (2023)

Telomeres and Telomerase in the Development of Liver Cancer
por: in der Stroth, Lena, et al.
Publicado: (2020)

Iron at the interface of immunity and infection
por: Nairz, Manfred, et al.
Publicado: (2014)

Molecular basis of HFE-hemochromatosis
por: Vujić, Maja
Publicado: (2014)

From the Ocean to the Lab—Assessing Iron Limitation in Cyanobacteria: An Interface Paper
por: Hunnestad, Annie Vera, et al.
Publicado: (2020)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
por: Asperti, Michela, et al.
Publicado: (2019)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

The Interface Between Iron Metabolism and Gene-Based Iron Contrast for MRI
por: Goldhawk, Donna E., et al.
Publicado: (2015)

Speciation of iron(II/III) at the iron-cement interface: a review
por: Wieland, Erich, et al.
Publicado: (2023)

Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development
por: Marchetti, Marialaura, et al.
Publicado: (2020)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Brazilian Landscape of Hepatocellular Carcinoma
por: Fonseca, Leonardo G., et al.
Publicado: (2023)

Hexadecylamine Adsorption at the Iron Oxide–Oil Interface
por: Wood, Mary H., et al.
Publicado: (2013)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma
por: Riggle, Kevin M., et al.
Publicado: (2016)

Sleep disorders: A review of the interface between restless legs syndrome and iron metabolism
por: Daubian-Nosé, Paulo, et al.
Publicado: (2014)

Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
por: Mocan, Tudor, et al.
Publicado: (2020)

The Immunology of Hepatocellular Carcinoma
por: Lawal, Gbemisola, et al.
Publicado: (2021)

Alcohol and hepatocellular carcinoma
por: Matsushita, Hiroshi, et al.
Publicado: (2019)

Pediatric hepatocellular carcinoma
por: Khanna, Rajeev, et al.
Publicado: (2018)

Epigenetics of hepatocellular carcinoma
por: Toh, Tan Boon, et al.
Publicado: (2019)

Macrophages and hepatocellular carcinoma
por: Tian, Zhiqiang, et al.
Publicado: (2019)

Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma
por: Liang, Jinying, et al.
Publicado: (2017)

The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma
por: Milosevic, Bojan, et al.
Publicado: (2023)

The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer
por: DeRosa, Angela, et al.
Publicado: (2021)

Hfe Deficiency Impairs Pulmonary Neutrophil Recruitment in Response to Inflammation
por: Benesova, Karolina, et al.
Publicado: (2012)

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7d5t0ni7khuap450aah8fs4fc1